205 related articles for article (PubMed ID: 15897573)
1. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI
Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573
[TBL] [Abstract][Full Text] [Related]
2. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of TROP2 expression in colorectal cancer.
Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
[TBL] [Abstract][Full Text] [Related]
4. Profiling markers of prognosis in colorectal cancer.
Lyall MS; Dundas SR; Curran S; Murray GI
Clin Cancer Res; 2006 Feb; 12(4):1184-91. PubMed ID: 16489072
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
7. RNA expression of cytochrome P450 in breast cancer patients.
Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P
Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058
[TBL] [Abstract][Full Text] [Related]
8. Profiling the expression of cytochrome P450 in breast cancer.
Murray GI; Patimalla S; Stewart KN; Miller ID; Heys SD
Histopathology; 2010 Aug; 57(2):202-11. PubMed ID: 20716162
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray.
Watanabe T; Kobunai T; Tanaka T; Ishihara S; Matsuda K; Nagawa H
Dis Colon Rectum; 2009 Dec; 52(12):1941-8. PubMed ID: 19934913
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid binding protein 6 is overexpressed in colorectal cancer.
Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M
Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific expression of cytochrome P450 CYP1B1.
Murray GI; Taylor MC; McFadyen MC; McKay JA; Greenlee WF; Burke MD; Melvin WT
Cancer Res; 1997 Jul; 57(14):3026-31. PubMed ID: 9230218
[TBL] [Abstract][Full Text] [Related]
12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
13. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
14. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
15. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
16. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
17. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
20. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
